Violante Di Donato

utbildad vid: Department of Statistical Sciences, Sapienza University of Rome, Campus Bio Medico University of Rome, La Sapienza, National Cancer Institute

sysselsättning: forskare

Serier

Det finns ingenting här

Skapa en ny serie

Verk

Det finns ingenting här

Skapa ett nytt verk

Artiklar 77

Datum

Titel

Författare

2022-07-06

Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients

Violante Di Donato, Andrea Giannini, Giusi Santangelo
2020-06-03

Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

Giuseppe Caruso, Violante Di Donato
2020-09-01

Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study

Francesca Falcone, Umberto Leone Roberti Maggiore, Violante Di Donato, Anna Myriam Perrone, Luigi Frigerio, Giuseppe Bifulco, Stephan Polterauer, Paolo Casadio, Gennaro Cormio, Valeria Masciullo, Mario Malzoni, Stefano Greggi
2020-11-01

Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups

Giorgio Bogani, Giovanni Apolone, Antonino Ditto, Giovanni Scambia, Pierluigi Benedetti Panici, Roberto Angioli, Sandro Pignata, Stefano Greggi, Paolo Scollo, Delia Mezzanzanica, Massimo Franchi, Fabio Martinelli, Mauro Signorelli, Salvatore Lopez, Violante Di Donato, Giorgio Valabrega, Maria Gabriella Ferrandina, Innocenza Palaia, Alice Bergamini, Luca Bocciolone, Antonella Savarese, Fabio Ghezzi, Jvan Casarin, Ciro Pinelli, Vito Trojano, Vito Chiantera, Giorgio Giorda, Francesco Sopracordevole, Mario Malzoni, Giovanna Salerno, Enrico Sartori, Antonia Carla Testa, Gianfranco Zannoni, Fulvio Zullo, Enrico Vizza, Giuseppe Trojano, Antonio Chiantera, Francesco Raspagliesi
2020-12-01

Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison

Giorgio Bogani, Andrea Ciavattini, Tommaso Simoncini, Marco Petrillo, Gaetano Valenti, Vincenzo Dario Mandato, Gabriele Carlifante, Stefano Ferla, Anna Myriam Perrone, Umberto Leone Roberti Maggiore, Simone Ferrero, Maria G Matarazzo, Raffaele Tinelli, Ludovico Muzii, Violante Di Donato, Arsenio Spinillo, Pierluigi Benedetti Panici, Margherita Fischetti, Giovanni Scambia, Paolo Vercellini
2019-05-01

Immunotherapy in endometrial cancer: new scenarios on the horizon

Chiara Di Tucci, Carmela Capone, Giulia Galati, Valentina Iacobelli, Michele Carlo Schiavi, Violante Di Donato, Ludovico Muzii, Pierluigi Benedetti Panici
2019-10-09

Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature

Violante Di Donato, Federica Tomao
2019-02-01

New diagnostic tools and therapeutic approaches in gynecology: considerations for innovative strategies

Violante Di Donato
2019-05-01

Oncological outcome of surgical management in patients with recurrent uterine cancer-a multicenter retrospective cohort study-CEEGOG EX01 Trial

Violante Di Donato, Fabio Martinelli, Francesco Raspagliesi, Giorgio Bogani, Valentina Chiappa
2019-07-14

Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain

Chiara Di Tucci, Violante Di Donato, Michele Vignali, Pierluigi Benedetti Panici, Giorgia Perniola, Ludovico Muzii, Mara Di Feliciantonio, Giulia Galati
2019-05-09

Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?

Federica Tomao, Violante Di Donato, Ludovico Muzii, Pierluigi Benedetti Panici, Innocenza Palaia
2019-02-01

Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: A meta-analysis

Violante Di Donato
2018-03-01

Impact of Hormone Receptor Status and Ki-67 Expression on Disease-Free Survival in Patients Affected by High-risk Endometrial Cancer

Violante Di Donato, Federica Tomao
2018-06-01

Combined Plasma Fibrinogen and Neutrophil Lymphocyte Ratio in Ovarian Cancer Prognosis May Play a Role?

Violante Di Donato
2018-10-01

Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis

Chiara Di Tucci, Violante Di Donato, Pierluigi Benedetti Panici, Ludovico Muzii, Mara Di Feliciantonio, Giulia Galati, Innocenza Palaia
2018-12-06

Fertility preservation in ovarian tumours

Violante Di Donato
2018-11-24

Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part I: Evaluation of efficacy

Violante Di Donato, Evangelos Kontopantelis, Tommaso Simoncini, Ludovico Muzii, Pierluigi Benedetti Panici, Michele Carlo Schiavi, Valentina Iacobelli, Ottavia D'oria
2018-11-28

Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part II: Evaluation of tolerability and safety

Violante Di Donato, Evangelos Kontopantelis, Tommaso Simoncini, Ludovico Muzii, Pierluigi Benedetti Panici, Michele Carlo Schiavi, Valentina Iacobelli, Ottavia D'oria
2018-08-22

The impact of CO2 laser for treatment of Bartholin's gland cyst or abscess on female sexual function: a pilot study

Violante Di Donato, Flaminia Vena, Federica Tomao
2018-11-16

Corrigendum to "Bartholin gland cancer" [Crit. Rev. Oncol./Hematol. 117 (September) (2017) 1-11]

Violante Di Donato, Flaminia Vena
2018-10-03

Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis

Violante Di Donato
2018-10-04

The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients

Violante Di Donato, Zoe Page, Carlotta Bracchi, Federica Tomao, Angela Musella, Giorgia Perniola, Pierluigi Benedetti Panici
2017-08-18

Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies

Violante Di Donato, Marco Monti, Federica Tomao
2017-03-24

Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer Staging

Fabio Martinelli, Umberto Leone Roberti Maggiore, Violante Di Donato, Francesco Raspagliesi, Giorgio Bogani, Mauro Signorelli, Stefania Perotto, Cono Scaffa, Chiara Borghi, Antonino Ditto, Valentina Chiappa, Domenica Lorusso, Luca Montanelli
2017-02-21

Severe pelvic organ prolapse treated by vaginal native tissue repair: long-term analysis of outcomes in 146 patients

Michele Carlo Schiavi, Violante Di Donato, Flaminia Vena, Marco Monti
2017-10-05

Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: Evaluation of feasibility and morbidity of different surgical techniques

Violante Di Donato, Lavinia Domenici, Andrea Giannini
2017-06-13

Bartholin gland cancer

Violante Di Donato, Flaminia Vena
2017-07-15

Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective study

Francesca Falcone, Giorgio Giorda, Fabio Ghezzi, Violante Di Donato, Umberto Leone Roberti Maggiore
2017-05-11

Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms.

Andrea Giannini, Chiara Di Tucci, Violante Di Donato, Marco Monti, Pierluigi Benedetti Panici, Giorgia Perniola, Ludovico Muzii, Michele Carlo Schiavi, Marzio Angelo Zullo
2017-09-26

Short-Infusion Trabectedin in Heavily Pretreated Ovarian Cancer Patients: A Single-Institution Experience

Violante Di Donato, Marco Monti
2016-02-01

Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma: A Systematic Review and Meta-analysis

Domenica Lorusso, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Violante Di Donato, Alice Indini, Giovanni D. Aletti, Francesco Raspagliesi, Giorgio Bogani, Cristina Donfrancesco
2016-03-24

Ixabepilone for the treatment of endometrial cancer

Claudia Marchetti, Violante Di Donato, Marco Monti

Människa - wd:Q41695515

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer